GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹3,328 Cr | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr | ₹3,159 Cr |
What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹3,328 Cr |
| Mar2024 | ₹1,609 Cr |
| Mar2023 | ₹3,877 Cr |
| Mar2022 | ₹3,593 Cr |
| Mar2021 | ₹3,159 Cr |
How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,328 Cr | 106.80 | |
| Mar2024 | ₹1,609 Cr | -58.49 | |
| Mar2023 | ₹3,877 Cr | 7.92 | |
| Mar2022 | ₹3,593 Cr | 13.75 | |
| Mar2021 | ₹3,159 Cr | - | |
Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹57,008.6 Cr | 1.2% | 4% | 43.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.2% |
4% |
43.9% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses